Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities
Journal of Cancer · 2026-01-01 · 17 (2) · 290-299
DOI: 10.7150/jca.122078 ↗At a glance
Übersichtsarbeit in Journal of Cancer, published on 2026-01-01. Written by Chengyuan Li and 5 co-authors. Institution: Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, China. Cited 3 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Povzetek ni na voljo.
Subjects
Author keywords
Authors and institutions
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, No. 300 Guangzhou Road, Nanjing, 210029, China.
Cite
APA
Li, C., Zhou, J., Zhang, L., Si, Y., Zhang, X., & Shen, M. (2026). Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. Journal of Cancer, 17(2), 290-299. https://doi.org/10.7150/jca.122078
Vancouver
Li C, Zhou J, Zhang L, Si Y, Zhang X, Shen M. Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities. Journal of Cancer. 2026;17(2):290-299. doi:10.7150/jca.122078
BibTeX
@article{Li2026,
author = {Li, Chengyuan and Zhou, Jianing and Zhang, Lijun and Si, Yan and Zhang, Xiang and Shen, Meiping},
title = {Sialylation in Thyroid Carcinoma: An Overview of Mechanisms, Markers, and Therapeutic Opportunities},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {2},
pages = {290--299},
doi = {10.7150/jca.122078}
}
EUVIMED